Ageing reduces potential for remyelination in multiple sclerosis
- PMID: 35641684
- DOI: 10.1038/s41582-022-00680-3
Ageing reduces potential for remyelination in multiple sclerosis
Comment on
-
Remyelination in humans due to a retinoid-X receptor agonist is age-dependent.Ann Clin Transl Neurol. 2022 Jul;9(7):1090-1094. doi: 10.1002/acn3.51595. Epub 2022 May 19. Ann Clin Transl Neurol. 2022. PMID: 35587315 Free PMC article.
References
Original article
-
- McMurran, C. E. et al. Remyelination in humans due to a retinoid-X receptor agonist is age-dependent. Ann. Clin. Neurol. https://doi.org/10.1002/acn3.51595 (2022) - DOI
Related articles
-
- Brown, J. W. L. et al. Safety and efficacy of bexarotene in patients with relapsing–remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study. Lancet Neurol. 9, 709–720 (2021) - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
